This book presents clinical, technical, and commercial information for the plasma fractionation industry. The book starts with a history of the industry that is followed by detailed chapters on all products covering biology, clinical use, manufacturing processes, and possible future improvements. In addition, there are chapters dealing with viral and prion issues and the operational areas including: manufacturing, regulatory, quality, medical information, and commercial evaluation. A final chapter provides a strategic overview and examines commercial, structural, and political opportunities and challenges that confront the industry now and in the future. With contributions from the major manufacturers of plasma proteins, the book is a comprehensive compilation on plasma protein production from the leading experts in the field.